Our mission at Abselion is to simplify protein quantification for the scientists making crucial decisions to accelerate the development of biotherapeutics. Our tools help researchers to develop the medicine of the future and to find the best ways to produce new biomolecules.
We focus on convenient tools with high degree of automation and low hands-on time to accelerate access to actionable data. Our award-winning Amperia system, built on proprietary Redox Electrochemical Detection (RED) technology, brings a new approach to biologics and viral-vector quantification for confident and cost-effective automated, at-line titre measurement, at any bench or bioreactor. By enabling agile and straightforward access to titre data, we empower scientists to focus on the decisions that can drive bioprocess optimisation and innovation.
We are a dynamic, interdisciplinary team working at the intersection of biology, nanotechnology and data science. We value a flat hierarchy, where everyone is encouraged to share their ideas and to follow their passion.
Company Details
- Employees
- 24
- Address
- 93 Lawrence Weaver Road, Cambridge,england Cb3 0le,united Kingdom
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- hexagonfab.com
- HQ
- Cambridge, England
Abselion Questions
Abselion's website is hexagonfab.com
Abselion's LinkedIn profile is https://uk.linkedin.com/company/abselion
Abselion has
24 employees.
View email and phone details for 24
employees at Abselion.
Abselion's industry is
Biotechnology Research
Abselion's top competitors are
Earlham Institute,
Omass Therapeutics,
Alchemab Therapeutics Ltd,
Immunocore,
Youseq,
Scancell,
Lightcast,
4basebio,
Fairjourney Biologics,
Bicycle Therapeutics.
Abselion's categories are Biotechnology Research
